NIH-funded research R01 grant

Effectiveness of COVID-19 vaccines in pregnant women and their infants

Official title: COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants

Funded at Kaiser Foundation Research Institute · NIH-11045601 · Data updated 2026-11-12

This study looks at how well COVID-19 vaccines work for pregnant women and their babies, focusing on preventing infections and hospital visits, while also finding out what helps or hinders pregnant women from getting vaccinated.

More COVID-19 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKaiser Foundation Research Institute
NIH-funded
Lab location1 site (Oakland, UNITED STATES)
Project startMarch 10, 2022
Project endFebruary 28, 2027
Funding year2025
Award (this year)$539,872
NIH project number5R01AI168373-04
Project IDNIH-11045601 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant women who are considering or have received a COVID-19 vaccine.

Less likely to help

Patients who are not pregnant or who do not plan to become pregnant may not receive direct benefits from this research.

What this research studies

This research investigates how effective COVID-19 vaccines are for pregnant women and their infants. It aims to determine the vaccine's ability to prevent COVID-19 infections and hospitalizations in pregnant women, as well as its effectiveness in protecting infants during their first year of life. The study will also explore vaccination rates among pregnant women and identify factors that influence whether they choose to get vaccinated. By gathering this information, the research seeks to provide clearer guidance on COVID-19 vaccination during pregnancy.

Why it matters

Potential benefit: If successful, this research could provide critical insights into the safety and effectiveness of COVID-19 vaccines for pregnant women and their infants, potentially leading to improved health recommendations.

How similar studies have gone: While there have been studies on COVID-19 vaccine effectiveness in general populations, this specific focus on pregnant women and infants is relatively novel and has not been extensively tested.

Where this research is happening

  • Kaiser Foundation Research Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Zerbo, Ousseny — Kaiser Foundation Research Institute
  • Study coordinator: Zerbo, Ousseny

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.